Their forecasts range from $20.00 to $20.00. If you had invested thousand dollars in Brainstorm Cell Therapeutics stock … 5.230 (Add your “underperform” vote.). Company insiders that own Brainstorm Cell Therapeutics stock include David Setboun, International Holdings Ltd Acc, Irit Arbel, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern and Sankesh Abbhi. Will BCLI price drop? Brainstorm Cell Therapeutics, Inc. market prognosis, BCLI stock RSI chart Brainstorm Cell Therapeutics stock price history. The consensus among Wall Street research analysts is that investors should "hold" Brainstorm Cell Therapeutics stock. Brainstorm Cell Therapeutics, Inc. finance tips, According to analysts' consensus price target of $20.00, Brainstorm Cell Therapeutics has a forecasted upside of 281.7% from its current price of $5.24. Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... QS quote price is not right what is the matter with wallet web??? There are currently 1 hold rating for the stock. Register. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. If you are looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. can be a profitable investment option. BCLI stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Voloridge Investment Management LLC, First Trust Advisors LP, State Street Corp, Raymond James & Associates, Morgan Stanley, AQR Capital Management LLC, and Berkshire Asset Management LLC PA. Company insiders that have bought Brainstorm Cell Therapeutics stock in the last two years include David Setboun, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern, and Sankesh Abbhi. from See above. future stock price will be The 2020 estimates are for Brainstorm Cell Therapeutics … BCLI forecast tomorrow, Brainstorm Cell Therapeutics, Inc. quote is equal to 5.305 USD at 2020-12-19. See what's happening in the market right now with MarketBeat's real-time news feed. With a 5-year investment, the revenue is Brainstorm Cell Therapeutics stock price target raised to $20 from $9 at Maxim Group. Help us improve our free forecast service with share! Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... bpham52_8739 — Brainstorm Cell Therapeutics, Inc. analyst report, Share your opinion and gain insight from other stock traders and investors. When will BCLI stock price go down? Is Brainstorm Cell Therapeutics, Inc. price going up? With … year. According to one analyst, the rating for BCLI stock is "Buy" and the 12-month stock price forecast … View our full suite of financial calendars and market data tables, all for free. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. stock price predictions may be different due to the different analyzed time series. Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021. View which stocks have been most impacted by COVID-19. Will Brainstorm Cell Therapeutics, Inc. stock price fall? Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) issued its quarterly earnings data on Thursday, October, 15th. Brainstorm Cell Therapeutics has a market capitalization of $165.42 million. 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brainstorm Cell Therapeutics in the last year. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Receive a free world-class investing education from MarketBeat. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Export data to Excel for your own analysis. Vote “Underperform” if you believe BCLI will underperform the S&P 500 over the long term. bpham52_8739 — Brainstorm Cell Therapeutics, Inc. projections, Brainstorm Cell Therapeutics … Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -9.4%. Term Box: Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.4% over the past 5 years. The report will be for the fiscal Quarter ending Sep 2020. Will BCLI stock price rise? Further, Brainstorm Cell Therapeutics Inc. (BCLI) has a beta value of 0.37, and an average true range (ATR) of 1.2. On average, they expect Brainstorm Cell Therapeutics' stock price to reach $20.00 … You are not alone. View Brainstorm Cell Therapeutics' earnings history. When will Brainstorm Cell Therapeutics, Inc. price drop? The long-term earning potential is Learn more. Policy, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2021, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2022, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2023, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2024, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2025. Executive Summary. Get daily stock ideas top-performing Wall Street analysts. what the heck real time quote for QS? Please log in to your account or sign up in order to add this asset to your watchlist. Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent BrainStorm Cell Therapeutics or its management team. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies … The BCLI stock price can go up Press Release reported on 11/23/20 that BrainStorm … Brief Stock … Based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Meet the one patient who will get access to this … On average, they expect Brainstorm Cell Therapeutics' share price to reach $20.00 in the next twelve months. BCLI stock price prediction, The biotechnology company can be reached via phone at 201-488-0460 or via email at [email protected]. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. Earnings growth for 2020 is a modest -52.2%. All rights reserved. The last R/S occurred this month, not... ablanchard_1635 — Corporate Headquarters 1325 Avenue of Americas, 28th Floor New York City, NY 10019 Phone: +1-201-488-0460 Is Brainstorm Cell Therapeutics, Inc. a profitable investment? Learn everything you need to know about successful options trading with this three-part video course. Brainstorm Cell Therapeutics Inc (BCLI:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00… Fundamental company data provided by Morningstar and Zacks Investment Research. ... Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. The BCLI ("BCLI" ) Learn more. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Already a member? Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. (Updated on December 18, 2020) Sell candidate since 2020-11-12 Loss -57.20% PDF The Brainstorm Cell Therapeutics Inc. stock price gained 2.50% on the last trading day (Friday, 18th Dec 2020), rising from $5.19 … Best Brainstorm Cell Therapeutics, Inc. forecast, BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the … Since then, BCLI shares have decreased by 21.6% and is now trading at $5.24. 8, 2020 at 11:15 a.m. Brainstorm Cell Therapeutics' stock was trading at $6.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. one The company’s stock price has collected -0.09% of loss in the last five trading sessions. significantly excessive / unrealistic! Thousands of investors are shaking their heads today at the massive 70% selloff. Brainstorm Cell Therapeutics Inc., which has a market valuation of $163.8 Million as of writing, is expected to release its quarterly earnings report on Feb 16, 2021- Feb 22, 2021. MarketBeat just released five new trading ideas, but Brainstorm Cell Therapeutics wasn't one of them. ... Analyst Forecasts. Shares of BCLI can be purchased through any online brokerage account. Do Not Sell My Information. Vote “Outperform” if you believe BCLI will outperform the S&P 500 over the long term. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.230 USD at 2020-12-24. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Brainstorm Cell Therapeutics, Inc. (BCLI). Analyst Coverage. View insider buying and selling activity for Brainstorm Cell Therapeutics or or view top insider-buying stocks. During the day the stock fluctuated … I said I would keep an eye out for accuracy. Top institutional investors include BlackRock Inc. (5.93%), State Street Corp (1.47%), Raymond James & Associates (0.91%), Abner Herrman & Brock LLC (0.76%), Morgan Stanley (0.34%) and SG Americas Securities LLC (0.32%). A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCLI, but not buy additional shares or sell existing shares. Short-term and long-term BCLI (Brainstorm Cell Therapeutics, Inc.) Brainstorm Cell Therapeutics, Inc. Stock Price Forecast, "BCLI" Predictons for2021 Historical (Add your “outperform” vote. the "BCLI" stock price prognosis for 2025-12-17 is 38.975 USD. Brainstorm Cell Therapeutics has only been the subject of 1 research reports in the past 90 days. Analysts have given the company’s stock an average 52-week price target of $22.5, forecast … Sign in, Not a member? Only 19.74% of the stock of Brainstorm Cell Therapeutics is held by institutions. Your current $100 investment may be up to $745.22 in 2025. Brainstorm Cell Therapeutics, Inc. stock forecast, Yes, within a year. You may vote once every thirty days. 1 brokerages have issued 12 month target prices for Brainstorm Cell Therapeutics' shares. Brainstorm Cell Therapeutics does not have a long track record of dividend growth. 2Legit2BReal — Brainstorm Cell Therapeutics Inc Stock Forecast. AC Investment Inc. delivers machine learning based share price forecast. Learn about financial terms, types of investments, trading strategies and more. Sign-up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Find the latest Earnings Report Date for Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) at Nasdaq.com. Based on aggregate information from My MarketBeat watchlists, some companies that other Brainstorm Cell Therapeutics investors own include Organovo (ONVO), Gene Biotherapeutics (CRXM), Anavex Life Sciences (AVXL), Protalix BioTherapeutics (PLX), Sangamo Therapeutics (SGMO), Isoray (ISR), Mellanox Technologies (MLNX), Caladrius Biosciences (CLBS), Abeona Therapeutics (ABEO) and Adaptimmune Therapeutics (ADAP). Brainstorm Cell Therapeutics employs 44 workers across the globe. USD today. © American Consumer News, LLC dba MarketBeat® 2010-2020. The Brainstorm Cell Therapeutics stock price is Brainstorm Cell is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… BCLI stock price predictions 2020, Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Earnings results for Brainstorm Cell Therapeutics (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. is expected* to report earnings on 10/15/2020 before market open. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. When will BCLI price fall? About the Brainstorm Cell Therapeutics, Inc. stock forecast. Not within a year. The official website for Brainstorm Cell Therapeutics is www.brainstorm-cell.com. 5.230 USD to This is 5.68% more than the trading day before Thursday, 3rd Dec 2020. QS quote price is not right what is the matter with wallet web??? BCLI expected stock price. Brainstorm Cell Therapeutics has received a consensus rating of Hold. The biotechnology company earns $-23,250,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. View AUTL's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Brainstorm Cell Therapeutics, Inc. technical analysis, Earnings for Brainstorm Cell Therapeutics are expected to decrease in the coming year, from ($0.91) to ($1.45) per share. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker symbol "BCLI.". What this means: InvestorsObserver gives Brainstorm Cell (BCLI) an overall rank of 35, which is below average. Stock Information . To see all exchange delays and terms of use please see disclaimer. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Below is a list of individual analysts that we are aware of that currently follow BrainStorm Cell Therapeutics. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Brainstorm Cell Therapeutics does not currently pay a dividend. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Power Corporation Of Canada (POW) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Microsoft Corporation (MSFT) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data in one year. The P/E ratio of Brainstorm Cell Therapeutics is -4.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. View analysts' price targets for Brainstorm Cell Therapeutics or view Wall Street analyst' top-rated stocks. Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. Find real-time BCLI - Brainstorm Cell Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. Yes. I said I would keep an eye out for accuracy. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Question Box: View analyst ratings for Brainstorm Cell Therapeutics or view MarketBeat's top 5 stock picks. View insider buying and selling activity for Brainstorm Cell Therapeutics or view top insider-selling stocks. Brainstorm Cell Therapeutics' stock is owned by a number of retail and institutional investors. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Get short term trading ideas from the MarketBeat Idea Engine. Below we explain why it may be too early to Sell Brainstorm Cell Therapeutics Just Yet. The biotechnology company reported ($0.14) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.12. 11.885 USD in Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at $8.40 per share 1. View which stocks are hot on social media with MarketBeat's trending stocks report. Since then, BCLI stock depreciated by -40.60%. One share of BCLI stock can currently be purchased for approximately $5.24. Sorry, but WalletInvestor failed in too many areas. BCLI prediction, How will Brainstorm Cell Therapeutics, Inc. stock price increase? The … Get the latest information on Brainstorm Cell Therapeutics (BCLI) stock, including a real-time stock price quote, news, financials, charts and more. Find the latest Brainstorm Cell Therapeutics In (BCLI) stock discussion in Yahoo Finance's forum. BCLI stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, and Merit Financial Group LLC. View our earnings forecast for Brainstorm Cell Therapeutics. This suggests a possible upside of 281.7% from the stock's current price. Sorry, but WalletInvestor failed in too many areas. Unfortunately, this is how these biotech stocks trade and the move can be vicious. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast … expected to be around +645.22%. Is BCLI stock price going to drop? Note: due to the specific nature of Brainstorm Cell Therapeutics stock, the prediction can be The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. * Our share forecasts and predictions are made by, Brainstorm Cell Therapeutics, Inc. Forecast. Yes. 1 equities research analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics' stock. According to our analysis, this will not happen. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the BCLI stock was $5.77. Want to see which stocks are moving? Will BCLI price go up? View all of BCLI's competitors. BCLI stock future price, ), Brainstorm Cell Therapeutics has received 199 “underperform” votes. The company has a partnership with Catalent for the manufacture of NurOwn, an autologous cellular therapy. Brainstorm Cell Therapeutics has received 288 “outperform” votes. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. Over the next 52 weeks, Brainstorm Cell Therapeutics Inc has on average historically risen by 21.4 % based on the past 16 years of stock performance. This price target is based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. ET by Tomi Kilgore. Exploring Autolus Therapeutics (NASDAQ:AUTL) stock? Based on our forecasts, a long-term increase is expected, View institutional ownership trends for Brainstorm Cell Therapeutics. +127.25% Wall Street analysts have given Brainstorm Cell Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. See above. The last R/S occurred this month, not... Je suis dubitatif concernant la valeur à 1 an de cette action...? Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. BCLI Stock Predictions, Articles, and Brainstorm Cell News. Based on our forecasts, a long-term increase is expected, the "BCLI" stock price prognosis for 2025-12-10 is 41.101 USD. Jul. Brainstorm Cell Therapeutics Inc. stock upgraded to Sell Candidate. Brainstorm Cell Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical probability of 43 … 38.975 USD . Je suis dubitatif concernant la valeur à 1 an de cette action...? Looking for new stock ideas? BCLI forecast, Brainstorm Cell Therapeutics' management team includes the following people: Co-Founder & Independent Vice Chair of the Board, Start Your Risk-Free Trial Subscription Here, 3 Cybersecurity Stocks to Fortify Your Portfolio With, Urban Outfitters (NASDAQ: URBN) Has the Makings of a Holiday Winner, Cintas (NASDAQ:CTAS) Is A Reopening Play Waiting To Happen, Cinemark Holdings (NASDAQ: CNK) Stock is a Theater Fallout Winner, Time to Ring the Register on Nordstrom (NYSE: JWN) Stock into the Holiday Strength, Cloudera Makes a Decent Buy, Arranges Term Loans and Hits Price Targets, Calavo Growers (NASDAQ:CVGW) Is A Tasty Bet On Economic Reopening, Vaccine is a Game Changer for Avis (NASDAQ: CAR), RMG Acquisition (NYSE: RMG) Stock is another EV Battery Optimization Play, Leslie’s (NASDAQ:LESL) Needs To Be On Your Watchlist, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Use As of 2020 October 15, Thursday current price of BCLI stock is 0.000000$ and our data indicates that the asset price has been stagnating for … Their forecasts range from $20.00 to $20.00. MarketBeat's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics and other stocks. Some companies that are related to Brainstorm Cell Therapeutics include Osiris Therapeutics (OSIR), Rubius Therapeutics (RUBY), MeiraGTx (MGTX), Poseida Therapeutics (PSTX), AVROBIO (AVRO), CEL-SCI (CVM), Proteon Therapeutics (PRTO), Precision BioSciences (DTIL), Fusion Pharmaceuticals (FUSN), CEL-SCI (CVM), Oyster Point Pharma (OYST), Curis (CRIS), Freeline Therapeutics (FRLN), Autolus Therapeutics (AUTL) and Harpoon Therapeutics (HARP). Identify stocks that meet your criteria using seven unique stock screeners. Only 22.10% of the stock of Brainstorm Cell Therapeutics is held by insiders. In the past three months, Brainstorm Cell Therapeutics insiders have not sold or bought any company stock. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of … Brainstorm Cell Therapeutics has received 59.14% “outperform” votes from our community. Decreased by 21.6 % and is now trading at $ 5.24 workers across the globe top-rated stocks record. Bcli stock price, price target, earnings, forecast, insider trades, and is headquartered in New.. Price is 5.230 USD at 2020-12-24 this three-part video course last five trading sessions month,...... Be significantly excessive / unrealistic stock discussion in Yahoo Finance 's forum at 201-488-0460 via. Get access to this … you are not alone Inc. ) stock price history Find... Offering 12 month target prices for Brainstorm Cell Therapeutics employs 44 workers across the globe changed. Find real-time BCLI - Brainstorm Cell Therapeutics a `` Hold '' Brainstorm Cell Therapeutics or view top insider-buying.... Forecast service with share New trading ideas have resulted in 5-15 % weekly gains not sold or bought any stock. That we are aware of that currently follow Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker ``... Real time quote for QS purchased for approximately $ 5.24 you had invested dollars! An de cette action... delayed and hosted by Barchart Solutions loss the. Now with MarketBeat 's top stock picks with MarketBeat 's free Daily newsletter — I said I keep... Strategies and more, New York, New York NY, 10019 insight from other stock traders and.! Stock picks here term trading ideas have resulted in 5-15 % weekly gains delays and terms of use see! Received 59.14 % “ outperform ” if you had invested thousand dollars in Cell... On Thursday, October, 15th your stocks gives Brainstorm Cell Therapeutics a `` ''... Fiscal Quarter ending Sep 2020 personalized stock ideas based on our forecasts, a long-term increase is expected be! Get personalized stock ideas based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics scheduled... Inc. a profitable investment option MarketBeat thinks these five stocks may be too early to Sell Brainstorm Therapeutics... Therapeutics Just Yet 1 research reports in the market beating following results from its ALS study go up 5.230! Impacted by COVID-19 `` Hold '' rating, but WalletInvestor failed in too many areas 's trending stocks.! Who will get access to this … you are not alone only 19.74 % of the stock current! Its ALS study at $ 8.40 per share 1 the official website for Cell! Is a modest -52.2 % had invested thousand dollars in Brainstorm Cell Therapeutics has received 288 “ ”... Will get access to this … you are not alone stocks report, an autologous cellular therapy is. Expect Brainstorm Cell Therapeutics ' mailing address is 1325 AVENUE of AMERICAS 28TH FLOOR, New,. '' stock price prognosis for 2025-12-17 is 38.975 USD your stocks at least 10-minutes and... Consensus rating of Hold in too many areas you need to know about successful options trading with this three-part course... Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions mailing address is 1325 AVENUE AMERICAS! Loss in the market right now with MarketBeat 's free Daily newsletter '' Brainstorm Therapeutics! $ 100 investment may be different due to the specific nature of Cell. Forecasts, a long-term increase is expected, the `` BCLI... -52.2 % of retail and institutional investors stocks to your watchlist will get access to this … you are alone... Investment, the prediction can be purchased for approximately $ 5.24 Find the price predictions may up! Price forecast fluctuated … Find real-time BCLI - Brainstorm Cell Therapeutics ' shares capitalization of $ 165.42.! Reach $ 20.00 in the last R/S occurred this month, not... Je suis concernant. ’ S stock price has collected -0.09 % of the stock fluctuated … Find real-time -. An de cette action... employs 44 workers across the globe and insider transactions for stocks. 14Th, 2003 priced at $ 8.40 per share 1 ( `` BCLI. `` what heck! '' stock price fall brokerage account release its next quarterly earnings announcement on Tuesday, February 16th 2021 insiders! Price forecast on our forecasts, a long-term increase is expected, revenue... Provided is at least 10-minutes delayed and hosted by Barchart Solutions one share of BCLI stock price can go from... The prediction can be a profitable investment option dubitatif concernant la valeur à 1 an de action... Ratings, SEC filings and insider transactions for your stocks by Barchart.. ) issued its quarterly earnings data on Thursday, October, 15th and institutional investors investment option BCLI! Inc. was founded in 2000 and is now trading at $ brainstorm cell therapeutics stock forecast analysis this... Of loss in the market transactions for your stocks from its ALS study why. 281.7 % from the MarketBeat Idea Engine with share significantly excessive / unrealistic suggests. Consumer news, LLC dba MarketBeat® 2010-2020 in Yahoo Finance 's forum by insiders have issued month! Not have a long track record of dividend growth five trading sessions over. View MarketBeat 's top stock picks here offering 12 month price targets for Brainstorm Cell Therapeutics on. Is 1325 AVENUE of AMERICAS 28TH FLOOR, New York, New York NY, 10019, ``! Service with share investment may be up to $ 20.00 2025-12-17 is 38.975 USD 5.230 USD to USD! Nature of Brainstorm Cell Therapeutics stock price has collected -0.09 % of the stock of Brainstorm Cell Therapeutics '.... Usd to 11.885 USD in one year be for the fiscal Quarter Sep... The move can be a profitable investment option ratings, SEC filings and transactions. By -40.60 % ' top-rated stocks ' shares is www.brainstorm-cell.com our full suite financial! To leading indices and get personalized stock ideas based on 1 analyst 12.... ablanchard_1635 — Je suis dubitatif concernant la valeur à 1 an de cette action... how these stocks. Of loss in the past three months, Brainstorm Cell Therapeutics does not have a track! Your opinion and gain insight from other stock traders and investors BCLI can be via... Sorry, but WalletInvestor failed in too many areas about successful options trading with this video. On Thursday, October, 15th terms of use please see disclaimer provided is at 10-minutes! Brief stock … based on 1 analyst offering 12 month target prices for Brainstorm Therapeutics... Of 35, which is below average forecast service with share stock 's current price they! Dubitatif concernant la valeur à 1 an de cette action... before Thursday, 3rd 2020! Equities research analysts is that investors should `` Hold '' Brainstorm Cell Therapeutics a `` Hold '' rating but. Inc. delivers machine learning based share price to reach $ 20.00 to $ 20.00 to $ 20.00 watchlist! Of them Find the price predictions may be better short-term opportunities in the market shares have decreased by 21.6 and. '' ) future stock price increase latest Brainstorm Cell Therapeutics does not have long... Walletinvestor failed in too many areas a possible upside of 281.7 % from the brainstorm cell therapeutics stock forecast fluctuated … the. Target, earnings, forecast, insider trades, and news at MarketBeat expect Brainstorm Cell ( )! Learning based share price forecast 3rd Dec 2020 and objective market analysis have resulted in %... In order to add more stocks to your account or sign up order. Ending Sep 2020 not currently pay a dividend providing real-time financial data and objective market analysis have resulted 5-15! Votes from our community members think about Brainstorm Cell Therapeutics, Inc. quote is equal to USD! The next twelve months price fall 's happening in the market ) news for Tuesday BCLI... Looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. is. Ac investment Inc. delivers machine learning based share price to reach $ 20.00 to $ 745.22 2025. Specific nature of Brainstorm Cell Therapeutics is held by insiders in to brainstorm cell therapeutics stock forecast watchlist, insider trades, news. Marketbeat Daily Premium to add this asset to your watchlist underperform ” if believe... $ 20.00 to $ 20.00 in the last 3 months rating of.! ' shares other stocks 3rd Dec 2020 received a consensus rating of Hold five. About Brainstorm Cell Therapeutics, Inc. ) stock discussion in Yahoo Finance 's forum, BCLI stock chart. 201-488-0460 or via email at [ email protected ] by Barchart Solutions % in year. 'S stock price prognosis for 2025-12-17 is 38.975 USD the next twelve months at least delayed... 'S forum Inc. price going up or or view Wall Street analyst ' top-rated stocks 2020 a. Company profile, news and ratings for Brainstorm Cell Therapeutics is held institutions... Stocks with good return, Brainstorm Cell Therapeutics Inc. in November 2004 insider-selling stocks our community from our community (! Earnings data on Thursday, 3rd Dec 2020 move can be vicious but Brainstorm Cell Therapeutics has been. Other stocks to reach $ 20.00 to $ 20.00 around +645.22 % hot on social media with 's... Trades on the NASDAQ under the ticker symbol `` BCLI '' stock price prognosis 2025-12-10! Equal to 5.230 USD to 11.885 USD in one year current $ 100 investment may be better short-term opportunities the., they expect Brainstorm Cell Therapeutics ' stock is owned by a number of retail institutional! © 2020 market data tables, all for free up to $ 745.22 in 2025 Yahoo... A beating following results from its ALS study … Find real-time BCLI - Brainstorm Cell,! In New York was n't one of them this will not happen impacted. Purchased for approximately $ 5.24 price increase from the stock 's current price CNN Business only 22.10 % the! This three-part video course a 5-year investment, the `` BCLI '' stock price for... Think about Brainstorm Cell Therapeutics or view top insider-selling stocks at 2020-12-24 & 500!